前列腺癌严重程度对局限期治疗功能结局的影响:CEASAR研究结果
CEASAR前瞻性观察研究纳入2117例接受根治性前列腺切除术或外照射放疗的局限期前列腺癌患者,按风险分组比较患者报告功能。低风险组放疗3年性功能评分高于手术组,高风险组差异无临床意义;失禁、肠道、刺激排尿及激素领域未见治疗与严重程度的临床显著交互作用。
要点
- 低风险患者放疗3年性功能评分高于手术(52 vs 39,p<0.001)。
- 高风险患者手术与放疗3年性功能差异无临床意义(32 vs 38,p=0.03)。
- 失禁、肠道、刺激排尿及激素领域无治疗与风险分组的临床显著交互作用。
核心结论
- 低风险前列腺癌患者放疗后3年性功能评分高于手术,高风险患者两种治疗3年性功能结局相似。
研究设计与样本
- CEASAR为前瞻性、基于人群的观察性研究,2011-2012年入组局限期前列腺癌患者。
- 2117例接受根治性前列腺切除术或外照射放疗的患者中,低风险817例、中风险902例、高风险398例。
- 使用26项扩展前列腺指数复合量表在基线及6、12、36个月测量患者报告疾病特异性功能。
主要发现
- 低风险组3年性功能评分:手术39分(95%CI 37-42)vs 放疗52分(95%CI 47-56),p<0.001。
- 高风险组3年性功能评分:手术32分(95%CI 28-35)vs 放疗38分(95%CI 33-42),p=0.03。
- 采用「勃起足以性交」的二分类定义时,各风险组手术与放疗3年无重大差异。
- 失禁、肠道、刺激排尿和激素领域未观察到治疗与癌症严重程度的临床显著交互效应。
关键数值与推荐
- 低风险组放疗3年性功能评分较手术高12分(p<0.001)。
- 高风险组手术与放疗3年性功能评分差异无临床意义(p=0.03)。
临床怎么用
- 低风险患者选择放疗可能获得更好的3年性功能评分。
- 高风险患者应被告知手术与放疗3年性功能结局相似。
- 高风险患者接受放疗时,性功能可能不如低风险患者接受放疗。
局限性
- 缺乏确立的扩展前列腺指数复合量表领域评分临床显著差异阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether prostate cancer severity modifies patient-reported functional outcomes after radical prostatectomy (RP) or external beam radiotherapy (EBRT) for localized cancer is unknown. OBJECTIVE: The purpose of this study was to determine whether differences in predicted function over time between RP and EBRT varied by risk group. DESIGN, SETTING, AND PARTICIPANTS: The Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study is a prospective, population-based, observational study that enrolled men with localized prostate cancer in 2011-2012. Among 2117 CEASAR participants who underwent RP or EBRT, 817 had low-risk, 902 intermediate-risk, and 398 high-risk disease. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Patient-reported, disease-specific function was measured using the 26-item Expanded Prostate Index Composite (at baseline and 6, 12, and 36 mo). Predicted function was estimated using regression models and compared by disease risk. RESULTS AND LIMITATIONS: Low-risk EBRT patients reported 3-yr sexual function scores 12 points higher than those of low-risk RP patients (RP, 39 points [95% confidence interval {CI}, 37-42] vs EBRT, 52 points [95% CI, 47-56]; p<0.001). The difference in 3-yr scores for high-risk patients was not clinically significant (RP, 32 points [95% CI, 28-35] vs EBRT, 38 points [95% CI, 33-42]; p=0.03). However, when using a commonly used binary definition of sexual function (erections firm enough for intercourse), no major differences were noted between RP and EBRT at 3 yr across low-, intermediate-, and high-risk disease strata. No clinically significant interactive effects between treatment and cancer severity were observed for incontinence, bowel, irritative voiding, and hormone domains. The primary limitation is the lack of firmly established thresholds for clinically significant differences in Expanded Prostate Index Composite domain scores. CONCLUSIONS: For men with low-risk prostate cancer, EBRT was associated with higher sexual function scores at 3 yr than RP; however, for men with high-risk prostate cancer, no clinically significant difference was noted. Men with high-risk prostate cancer should be counseled that EBRT and RP carry similar sexual function outcomes at 3 yr. PATIENT SUMMARY: In this report, we studied the urinary, sexual, bowel, and hormonal functions of patients 3 yr after undergoing prostate cancer surgery or radiation. We found that for patients with high-risk disease, sexual function was similar between surgery and radiation. We conclude that high-risk patients undergoing radiation therapy should be counseled that sexual function may not be as good as low-risk patients undergoing radiation.
引用
- Tyson MD, Koyama T, Lee D, et al. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. Eur Urol. 2018. PMID: 29501451. doi:10.1016/j.eururo.2018.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。